---
title: 'Cost-effectiveness of endovascular treatment versus best medical management
  in basilar artery occlusion stroke: A U.S. healthcare perspective'
date: '2023-10-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37905959/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231101180626&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Two recent studies showed clinical benefit for endovascular
  treatment (EVT) in basilar artery occlusion (BAO) stroke up to 12 h (ATTENTION)
  and between 6 and 24 h from onset (BAOCHE). Our aim was to investigate the cost-effectiveness
  of EVT from a U.S. healthcare ...'
disable_comments: true
---
INTRODUCTION: Two recent studies showed clinical benefit for endovascular treatment (EVT) in basilar artery occlusion (BAO) stroke up to 12 h (ATTENTION) and between 6 and 24 h from onset (BAOCHE). Our aim was to investigate the cost-effectiveness of EVT from a U.S. healthcare ...